Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Dipeptide-2 | Dipeptide-2 is a synthetic peptide used for skin care. It can inhibit angiotensin converting enzyme ACE, enhance the lymphatic circulation of the eye, promote water discharge, and effectively eliminate edema and reduce eye bags. Uses: Dipeptide-2 is a compound composed of valine and tryptophan. in general, peptides are short chains of amino acids that can function as signaling molecules, influencing a variety of physiological processes. dipeptide-2 has been specifically implicated in enhancing lymphatic circulation and reducing inflammation, making it particularly effective in cosmetic formulations designed to reduce puffiness. Group: Pharmaceutical. Alternative Names: L-VALYL-L-TRYPTOPHAN; H-VAL-TRP-OH; VAL-TRP; N-valyltryptophan; L-Valyl-L-tyrosine; Dipeptide Val-Try. CAS No. 24587-37-9. Pack Sizes: 1 g. Product ID: BAT-010786. Molecular formula: C16H21N3O3. Mole weight: 303.36. Custom synthesis is available. Send your inquiries for more information. |  London |
| Dipeptide diaminobutyroyl benzylamide diacetate | Dipeptide diaminobutyroyl benzylamide is a biomimetic peptide and a muscarinic acetylcholine receptor antagonist. It mimics the action of the temple viper venom peptide Waglerin-1 to block sodium uptake and induce muscle relaxation. A cosmetic formulation acts as an anti-wrinkle ingredient used in anti-aging products. Group: Pharmaceutical. Alternative Names: H-β-Ala-Pro-Dab-NH-benzyl acetate; H-β-Ala-Pro-DabNHBz acetate; Syn-Ake acetate; Snake trippetide acetate; (2S)-beta-Alanyl-L-prolyl-2,4-diamino-N-(phenylmethyl)butanamide acetate; BCP18324; Butanamide, β-alanyl-L-prolyl-2,4-diamino-N-(phenylmethyl)-, (2S)-, acetate (1:2); Butanamide, β-alanyl-L-prolyl-2,4-diamino-N-(phenylmethyl)-, (2S)-, diacetate; Dipeptide diaminobutyryl benzylamide diacetate; SYN-AKE. CAS No. 823202-99-9. Pack Sizes: 1 g. Product ID: BAT-010789. Molecular formula: C19H29N5O3.2C2H4O2. Mole weight: 495.57. Custom synthesis is available. Send your inquiries for more information. | London |
| Palmitoyl Dipeptide-7 | Palmitoyl Dipeptide-7. Group: Pharmaceutical. Alternative Names: Palmitoyl dipeptide-7; PAL-KT; Palmitoyl-lysine-threonine. CAS No. 911813-90-6. Pack Sizes: 5 mg. Product ID: BAT-006231. Molecular formula: C26H51N3O5. Mole weight: 485.7. Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Tyr-Arg-cetyl ester | Ac-Tyr-Arg-cetyl ester is an ingredient in anti-wrinkle cosmetics. It can inhibit the production of calcitonin gene-related peptide (CGRP), produce β-endorphins, and raise the threshold of skin sensitivity to heat. Group: Pharmaceutical. Alternative Names: L-Arginine, N-acetyl-L-tyrosyl-, hexadecyl ester; Acetyl dipeptide-1 cetyl ester; Calmosensine; Calmosensine (cosmetic ingredient); Idealift; Acetyl tyrosylarginine cetyl ester; N-Acetyl dipeptide-1 cetyl ester. CAS No. 196604-48-5. Pack Sizes: 5 mg. Product ID: BAT-006228. Molecular formula: C33H57N5O5. Mole weight: 603.84. Custom synthesis is available. Send your inquiries for more information. | London |
| Aspartame | Aspartame is an artificial, non-saccharide sweetener used as a sugar substitute in some foods and beverages. Uses: Aspartame is a dipeptide compound composed of two amino acids (aspartic acid and phenylalanine) and a methyl ester bond. it was discovered in 1965 and approved for use by the u.s. food and drug administration (fda) in 1981. aspartame is extremely sweet, about 200 times sweeter than sucrose (table sugar), so only a very small amount is needed to achieve the desired sweetness. aspartame is often use. Group: Pharmaceutical. Alternative Names: L-α-Aspartyl-L-phenylalanine 2-Methyl Ester; Canderel; Dipeptide Sweetener; E 951; Equal; Finn; L-Aspartame; NutraSweet; Pal Sweet; Palsweet Diet; Sweet Dipeptide; Zero-Cal; α-Aspartame; α-L-Aspartyl-L-phenylalanine Methyl Ester; α-Sweet. CAS No. 22839-47-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-015427. Molecular formula: C14H18N2O5. Mole weight: 294.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Bestim TFA | Bestim TFA is an immunomodulatory dipeptide. Group: Pharmaceutical. Alternative Names: H-γ-Glu-Trp-OH trifluoroacetic acid; gamma-glutamyltryptophan trifluoroacetic acid; H-gGlu-Trp-OH trifluoroacetic acid; L-gamma-glutamyl-L-tryptophan trifluoroacetic acid. Pack Sizes: 100 mg. Product ID: B1370-099138. Molecular formula: C18H20F3N3O7. Mole weight: 447.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Cyclo(L-Leu-L-Pro) | Cyclo (-Leu-Pro) is a cyclic dipeptide containing leucine and proline. Group: Pharmaceutical. Alternative Names: cyclo(Leu-Pro); Cyclo(L-leucyl-L-prolyl). CAS No. 2873-36-1. Pack Sizes: 1 g. Product ID: BAT-010167. Molecular formula: C11H18N2O2. Mole weight: 210.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Ser(tBu)-Ser(tBu)-OH | Fmoc-Ser(tBu)-Ser(tBu)-OH is a protected dipeptide used in peptide synthesis. It features an Fmoc (Fluorenylmethyloxycarbonyl) group at the N-terminus, which protects the amino group during synthesis. Each Ser (Serine) residue is protected by a tBu (tert-butyl) group at the hydroxyl side chain, preventing unwanted side reactions. The -OH at the C-terminus indicates a free carboxyl group, allowing the dipeptide to be coupled with other amino acids. This compound is used to incorporate serine residues into peptides while maintaining the integrity of the hydroxyl groups for selective deprotection later in the synthesis process. Group: Pharmaceutical. Alternative Names: N-(Fluorenylmethoxycarbonyl)-O-tert-butyl-L-seryl-O-tert-butyl-L-serine; (S)-2-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(tert-butoxy)propanamido)-3-(tert-butoxy)propanoic acid; L-Serine, O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-seryl-O-(1,1-dimethylethyl)-; L-Serine, O-(1,1-dimethylethyl)-N-[O-(1,1-dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-seryl]-; N-(N-. CAS No. 110098-50-5. Pack Sizes: 100 mg. Product ID: BAT-002488. Molecular formula: C29H38N2O7. Mole weight: 526.62. Custom synthesis is available. Send your inquiries for more information. | London |
| Glu-Asp-OH | Glu-Asp-OH is a dipeptide used as a diagnostic indicator of the disease. Group: Pharmaceutical. Alternative Names: L-α-Glutamyl-L-aspartic acid; Vesilute; (S)-2-((S)-2-Amino-4-carboxybutanamido)succinic acid. CAS No. 3918-84-1. Pack Sizes: 1 g. Product ID: BAT-004999. Molecular formula: C9H14N2O7. Mole weight: 262.22. Custom synthesis is available. Send your inquiries for more information. | London |
| Homocarnosine acetate | L-Homocarnosine is a human metabolite and a brain-specific dipeptide of γ-aminobutyric acid (GABA) and histidine. Group: Pharmaceutical. Alternative Names: L-Homocarnosine acetate. Pack Sizes: 10 mg. Product ID: BAT-017111. Molecular formula: C12H20N4O5. Mole weight: 300.31. Custom synthesis is available. Send your inquiries for more information. | London |
| JE-2147 | JE-2147 is a dipeptide HIV protease inhibitor (PI) that is effective against a wide spectrum of HIV-1, HIV-2, simian immunodeficiency virus, and various clinical HIV-1 strains in vitro. Group: Pharmaceutical. Alternative Names: JE-2147;186538-00-1;KNI-764;AG1776;AG 1776;CHEMBL300891;(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylbutanoyl]-5,5-dimethyl-N-[(2-methylphenyl)methyl]-1,3-thiazolidine-4-carboxamide;(4r)-3-{(2s,3s)-2-Hydroxy-3-[(3-Hydroxy-2-Methylbenzoyl)amino]-4-Phenylbutanoyl}-5,5-Dimethyl-N-(2-Methylbenzyl)-1,3-Thiazolidine-4-Carboxamide;(4R)-3-[(2S,3S)-2-hydroxy-3-[(3-hydroxy-2-methyl. CAS No. 186538-00-1. Pack Sizes: 10 mg. Product ID: B2693-008706. Molecular formula: C32H37N3O5S. Mole weight: 575.72. Custom synthesis is available. Send your inquiries for more information. | London |
| L-α-Aspartyl-D-phenylalanine methyl ester | L-α-Aspartyl-D-phenylalanine methyl ester, a dipeptide compound, bears promise in the biomedical sector for its potential inhibitory impact on angiotensin converting enzyme (ACE), thus potentially reducing blood pressure levels. It has also shown potential in the treatment of hypertensive, cardiac failure, and other cardiovascular conditions. The study of its properties continues to generate interest and attention from academia and the scientific community. Group: Pharmaceutical. Alternative Names: L-alpha-Aspartyl-D-phenylalanine methyl ester. CAS No. 22839-65-2. Pack Sizes: 50 mg. Product ID: B2699-116576. Molecular formula: C14H18N2O5. Mole weight: 294.3. Custom synthesis is available. Send your inquiries for more information. | London |
| L-Carnosine | L-Carnosine is a dipeptide concentrated in muscle and brain tissue. It acts as an antioxidant that scavenges reactive oxygen species (ROS) and transition metal ions. It is also a neurotransmitter in the brain. L-Carnosine has potential antioxidant and anti-glycosylation activities, preventing acetaldehyde-induced non-enzymatic glycosylation and protein coupling. It is also a substrate for carnosinase detection, which can maintain pH balance in the body and extend cell life. Group: Pharmaceutical. Alternative Names: Carnosine; β-Alanyl-L-histidine; (2S)-2-(3-Aminopropanamido)-3-(1H-imidazol-4-yl)propanoic acid; Dragosine; Ignotin; Ignotine; Karnozin; N-(β-Alanyl)-L-histidine; NSC 524045; Sevitin; β-Alanylhistidine. CAS No. 305-84-0. Pack Sizes: 100 g. Product ID: BAT-008152. Molecular formula: C9H14N4O3. Mole weight: 226.24. Custom synthesis is available. Send your inquiries for more information. | London |
| L-Pyroglutamic Anhydride | An impurity of Pidotimod which is a synthetic dipeptide molecule with biological and immunological activity on both the adaptive and the innate immune responses. Group: Pharmaceutical. Alternative Names: (5aS,10aS)-Tetrahydrodipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone; (5aS,10aS)-tetrahydro-3H,5H-dipyrrolo[1,2-a:1',2'-d]pyrazine-3,5,8,10(2H,5aH)-tetraone. CAS No. 14842-41-2. Pack Sizes: 500 mg. Product ID: B1370-103506. Molecular formula: C10H10N2O4. Mole weight: 222.2. Custom synthesis is available. Send your inquiries for more information. | London |
| Mifamurtide | Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. It is a derivative of the mycobacterial cell wall component MDP and activates both monocytes and macrophages. It is an immunomodulator with antitumor effects that appear to be mediated via activation of monocytes and macrophages. It has orphan drug status for the treatment of osteosarcoma in the US and EU. Group: Pharmaceutical. Alternative Names: Mepact; CGP-19835; CGP 19835; CGP19835; MTP-PE; MTP-cephalin; L-MTP-PE; MLV19835. CAS No. 83461-56-7. Pack Sizes: 1mg;1g;10g. Product ID: 83461-56-7. Molecular formula: C59H109N6O19P. Mole weight: 1237.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Mifamurtide Sodium Hydrate | Mifamurtide is a liposomal formulation containing a muramyl dipeptide (MDP) analogue with potential immunomodulatory and antineoplastic activities. It is a derivative of the mycobacterial cell wall component MDP and activates both monocytes and macrophages. It is an immunomodulator with antitumor effects that appear to be mediated via activation of monocytes and macrophages. It has orphan drug status for the treatment of osteosarcoma in the US and EU. Group: Pharmaceutical. Alternative Names: L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, monosodium salt, hydrate; L-Alaninamide, N-(N-acetylmuramoyl)-L-alanyl-D-α-glutaminyl-N-[(7R)-4-hydroxy-4-oxido-10-oxo-7-[(1-oxohexadecyl)oxy]-3,5,9-trioxa-4-phosphapentacos-1-yl]-, sodium salt, hydrate (1:1:?). CAS No. 838853-48-8. Pack Sizes: 1mg;1g;10g. Product ID: 838853-48-8. Molecular formula: C59H109N6O19P.xH2O.Na. Mole weight: 1237.50 (anhydrous free base). Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Carnosine | N-Acetyl Carnosine is a naturally-occurring dipeptide used in the treatment of cataracts and in the treatment of UV-induced immunosuppression. Group: Pharmaceutical. Alternative Names: NAC, N-α-Acetyl-N-β-alanyl-L-histidine; N-Acetylcarnosine. CAS No. 56353-15-2. Pack Sizes: 1 g. Product ID: BAT-006160. Molecular formula: C11H16N4O4. Mole weight: 268.27. Custom synthesis is available. Send your inquiries for more information. | London |
| N-L-γ-glutamyl-L-tyrosine | N-L-γ-glutamyl-L-tyrosine is a dipeptide produced by the catabolism of proteins. Group: Pharmaceutical. Alternative Names: Gamma-Glutamyltyrosine; H-gamma-Glu-Tyr-OH; H-Glu(Tyr-OH)-OH. CAS No. 7432-23-7. Pack Sizes: 1 g. Product ID: BAT-015508. Molecular formula: C14H18N2O6. Mole weight: 310.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Phe-Phe-OMe HCl | Phe-Phe-OMe HCl is employed as a reagent used in the preparation of polymer nanoparticles containing hydrophobic dipeptide for inhibition of amyloid-β fibrillation. Group: Pharmaceutical. Alternative Names: H-Phe-Phe-OMe HCl; Methyl L-phenylalanyl-L-phenylalaninate hydrochloride; L-Phenylalanyl-L-phenylalanine methyl ester hydrochloride; (S)-Methyl 2-((S)-2-amino-3-phenylpropanamido)-3-phenylpropanoate hydrochloride. CAS No. 38017-65-1. Pack Sizes: 10 g. Product ID: BAT-006532. Molecular formula: C19H23ClN2O3. Mole weight: 362.86. Custom synthesis is available. Send your inquiries for more information. | London |
| Pidotimod | Pidotimod is a synthetic dipeptide molecule with biological and immunological activity on both the adaptive and the innate immune responses. Group: Pharmaceutical. Alternative Names: Pidotomod; PGT/1A; PGT 1A; PGT1A; PGT-1A. CAS No. 121808-62-6. Pack Sizes: 25 g. Product ID: NP3482. Molecular formula: C9H12N2O4S. Mole weight: 244.27. Custom synthesis is available. Send your inquiries for more information. | London |
| Talabostat mesylate | Talabostat mesylate is the orally bioavailable mesylate salt of an amino boronic dipeptide with antineoplastic and hematopoiesis- stimulating activities. By cleaving N-terminal Xaa-Pro or Xaa-Ala residues, talabostat inhibits dipeptidyl peptidases, such as fibroblast activation protein (FAP), resulting in the stimulation of cytokine and chemokine production and specific T-cell immunity and T-cell- dependent activity. This agent may also stimulate the production of colony stimulating factors, such as granulocyte colony stimulating factor (G-CSF), resulting in the stimulation of hematopoiesis. Dipeptidyl peptidases are involved in the activation of polypeptide hormones and chemokines. Uses: For research used only. Group: Pharmaceutical. Alternative Names: (R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic acid methanesulfonic acid (1:1); PT-100; PT100; PT 100; D05989; D-05989; D 05989; Val-boro-pro; Talabostat. CAS No. 150080-09-4. Pack Sizes: 20 mg. Product ID: B0084-084554. Molecular formula: C10H23BN2O6S. Mole weight: 310.17. Custom synthesis is available. Send your inquiries for more information. | London |
| 1,1-Dimethylethyl N-[(3R)-1-[(2-cyanophenyl)methyl]-3-piperidinyl]carbamate | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. Alternative Names: Carbamic acid, N-[(3R)-1-[(2-cyanophenyl)methyl]-3-piperidinyl]-, 1,1-dimethylethyl ester. CAS No. 1353254-15-5. Pack Sizes: 100 mg. Product ID: B1370-425896. Molecular formula: C18H25N3O2. Mole weight: 315.41. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-[[3,4-Dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]benzonitrile | An impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. Alternative Names: Benzonitrile, 2-[[3,4-dihydro-3-methyl-2,4-dioxo-6-[(3R)-3-piperidinylamino]-1(2H)-pyrimidinyl]methyl]-. CAS No. 2089611-85-6. Pack Sizes: 100 mg. Product ID: B1370-425895. Molecular formula: C18H21N5O2. Mole weight: 339.39. Custom synthesis is available. Send your inquiries for more information. | London |
| 2,4,5-Trifluoro-L-β-homophenylalanine hydrochloride | 2,4,5-Trifluoro-L-β-homophenylalanine hydrochloride is used as a reagent in the synthesis of valuable β-amylalkyl-β-amino acid enantiomers. It is also an impurity of Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: (S)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid hydrochloride. CAS No. 1217809-78-3. Pack Sizes: 1mg;1g;10g. Product ID: BAT-006713. Molecular formula: C10H11ClF3NO2. Mole weight: 269.65. Custom synthesis is available. Send your inquiries for more information. | London |
| 2-(Chloromethyl)-4-methylquinazoline | 2-(Chloromethyl)-4-methylquinazoline is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Group: Pharmaceutical. Alternative Names: 2-(Chloromethyl)-4-methylquinazoline; Linagliptin Impurity 44; NSC 48971; Linagliptin 2-Chloromethyl Impurity. CAS No. 109113-72-6. Pack Sizes: 1mg;1g;10g. Product ID: NP2671. Molecular formula: C10H9ClN2. Mole weight: 192.65. Custom synthesis is available. Send your inquiries for more information. | London |
| (2'R,2S,cis)-Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Alternative Names: (1S,3S,5S)-2-[(2R)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile. CAS No. 1564265-93-5. Pack Sizes: 2.5 mg. Product ID: B0016-007240. Molecular formula: C18H25N3O2. Mole weight: 315.417. Custom synthesis is available. Send your inquiries for more information. | London |
| (2R)-Vildagliptin | (2R)-Vildagliptin is an R-enantiomer of Vildagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor used as an anti-hyperglycemic agent and an anti-diabetic drug. Group: Pharmaceutical. Alternative Names: Vildagliptin Related Compound A; (2R)-1-[2-[[(5S,7R)-3-hydroxy-1-adamantyl]amino]acetyl]pyrrolidine-2-carbonitrile. CAS No. 1036959-27-9. Pack Sizes: 20 mg. Product ID: B0020-461928. Molecular formula: C17H25N3O2. Mole weight: 303.406. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Aminoadamantan-1-ol | An impurity of Vildagliptin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. Alternative Names: 3-Amino-1-hydroxyadamantane; 1-Amino-3-adamantanol; Tricyclo[3.3.1.13,7]decan-1-ol, 3-amino-; 1-Adamantanol, 3-amino-; 3-Aminotricyclo[3.3.1.13,7]decan-1-ol; (3-Hydroxyadamantan-1-yl)amine; 1-Amino-3-hydroxyadamantane; 3-Amino-1-adamantanol. CAS No. 702-82-9. Pack Sizes: 1mg;1g;10g. Product ID: NP3360. Molecular formula: C10H17NO. Mole weight: 167.25. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Deoxy Saxagliptin | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Alternative Names: (1S,3S,5S)-2-[(2S)-2-Amino-2-tricyclo[3.3.1.13,7]dec-1-ylacetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile. CAS No. 361441-98-7. Pack Sizes: 2.5 mg. Product ID: B0016-007241. Molecular formula: C18H25N3O. Mole weight: 299.41. Custom synthesis is available. Send your inquiries for more information. | London |
| 3-Descarbonitrile 3-Acetamido Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. Alternative Names: Saxagliptin EP Impurity B; (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo [3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carboxamide. CAS No. 1496712-39-0. Pack Sizes: 2.5 mg. Product ID: B0016-479445. Molecular formula: C18H27N3O3. Mole weight: 333.43. Custom synthesis is available. Send your inquiries for more information. | London |
| 4-((2-Hydroxyethoxy)carbonyl)benzoic acid | 4-((2-Hydroxyethoxy)carbonyl)benzoic acid, an essential pharmaceutical intermediate widely utilized for synthesizing dipeptidyl peptidase-4 (DPP-4) inhibitors, possesses potential anti-cancer properties with its pronounced efficacy in chronic myeloid leukemia (CML) and other cancer treatments. Plausible and encouraging observations in cancer research elucidate its immense promise as a therapeutic agent. Group: Pharmaceutical. Alternative Names: 2-Hydroxyethyl terephthalate. CAS No. 1137-99-1. Pack Sizes: 100 mg. Product ID: B2699-223434. Molecular formula: C10H10O5. Mole weight: 210.18. Custom synthesis is available. Send your inquiries for more information. | London |
| 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione | 7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is an impurity of Linagliptin. Linagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) that is a medication used to treat type 2 diabetes in conjunction with exercise and diet. Group: Pharmaceutical. Alternative Names: Linagliptin Impurity 33; 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-8-(methylamino)-1-[(4-methyl-2-quinazolinyl)methyl]. CAS No. 2468656-63-3. Pack Sizes: 50 mg. Product ID: B1370-426211. Molecular formula: C21H21N7O2. Mole weight: 403.45. Custom synthesis is available. Send your inquiries for more information. | London |
| 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine; 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; Linagliptin Impurity A. CAS No. 853029-57-9. Pack Sizes: 25 g. Product ID: B1370-329178. Molecular formula: C20H17BrN6O2. Mole weight: 453.29. Custom synthesis is available. Send your inquiries for more information. | London |
| Alogliptin benzoate | Alogliptin benzoate(SYR 322) is a potent, selective inhibitor of DPP-4 with IC50 of <10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. Alternative Names: 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate. CAS No. 850649-62-6. Pack Sizes: 1mg;1g;10g. Product ID: NP3041. Molecular formula: C25H27N5O4. Mole weight: 461.522. Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-2-fluoro-D-β-homophenylalanine | Boc-2-fluoro-D-β-homophenylalanine is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: (R)-3-((tert-butoxycarbonyl)amino)-4-(2-fluorophenyl)butanoic acid; Boc-D-β-HomoPhe(2-F)-OH; Boc-(R)-3-amino-4-(2-fluorophenyl)butyric acid. CAS No. 218608-98-1. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008041. Molecular formula: C15H20FNO4. Mole weight: 297.32. Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-3,4-difluoro-D-beta-homophenylalanine | Boc-3,4-difluoro-D-beta-homophenylalanine is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: Boc-(R)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid; (R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid. CAS No. 269396-59-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-008042. Molecular formula: C15H19F2NO4. Mole weight: 315.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Boc-Saxagliptin | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. Alternative Names: N-[(1S)-2-[(1S,3S,5S)-3-cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]-Carbamic Acid 1,1-Dimethylethyl Ester; Saxagliptin Impurity 16. CAS No. 709031-43-6. Pack Sizes: 25 mg. Product ID: B1370-149516. Molecular formula: C23H33N3O4. Mole weight: 415.54. Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin Ammonium Salt | Cilastatin Ammonium Salt is the ammonium salt of Cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. Alternative Names: (2Z)-7-[[(2R)-2-amino-2-carboxyethyl]thio]-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic Acid Ammonium Salt; MK-791 Ammonium Salt. CAS No. 877674-82-3. Pack Sizes: 500 mg. Product ID: B2693-468925. Molecular formula: C16H29N3O5S. Mole weight: 375.48. Custom synthesis is available. Send your inquiries for more information. | London |
| Cilastatin sodium | Cilastatin sodium is the sodium salt of cilastatin, which is a dipeptidase inhibitor of renal enzyme dehydropeptidase-I and leukotriene D4 peptidase. It inhibits metabolism of LTD4 to LTE4 and the hydrolysis of β-lactam antibiotics. It reduces toxic accumulation of cyclosporin A in kidney proximal tubule epithelial cells. It can be combined intravenously with imipenem in order to protect it from dehydropeptidase. It suppresses both host and target metabolism of the broad-spectrum antibiotic imipenem, improving its efficacy. It usually confers antibiotic resistance to certain bacteria because itself does not have antibiotic activity. It has nephroprotective effects. Group: Pharmaceutical. Alternative Names: L 642957; MK 791; L642957; MK791; L-642957; MK-791; [R-[R*,S*-(Z)]]-7-[(2-Amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-2-heptenoic Acid Monosodium Salt; (2Z)?-7-[[(2R)?-2-Amino-2-carboxyethyl]?thio]?-2-[[[(1S)?-2,?2-dimethylcyclopropyl]?carbonyl]?amino]?-2-heptenoic Acid Sodium Salt; sodium S-((Z)-6-carboxy-6-((S)-2,2-dimethylcyclopropane-1-carboxamido)hex-5-en-1-yl)-L-cysteinate. CAS No. 81129-83-1. Pack Sizes: 1 g. Product ID: B0084-077802. Molecular formula: C16H25N2NaO5S. Mole weight: 380.43. Custom synthesis is available. Send your inquiries for more information. | London |
| Cysteinyl-3M3SH | Cysteinyl-3M3SH is an intermediate in the bacterial biotransformation of the odourless physiological malodour precursor Cys-Gly-3M3SH. Cys-Gly-3M3SH is actively transported by the di-/tri-peptide transporter (DtpT) along with the movement of protons. Once inside the cell the terminal glycine is cleaved by a dipeptidase (PepA) to release Cys-3M3SH. Group: Pharmaceutical. Alternative Names: Cys-3M3SH. Pack Sizes: 250 mg. Product ID: BAT-014377. Molecular formula: C10H21NO3S. Mole weight: 235.34. Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A | It is produced by the strain of Bacillus cereus BMF 657-RF1. It can inhibit Dipeptidyl amino peptidase IV and immune enhancement effect. Group: Pharmaceutical. Alternative Names: Ile-Pro-Ile; isoleucylprolylisoleucine; l-isoleucyl-l-prolyl-l-isoleucine; N-(1-L-Isoleucyl-L-prolyl)-L-isoleucine; isoleucyl-prolyl-isoleucine; L-Isoleucine, N-(1-L-isoleucyl-L-prolyl)-; (2S,3S)-2-((S)-1-((2S,3S)-2-Amino-3-methylpentanoyl)pyrrolidine-2-carboxamido)-3-methylpentanoic acid; H-Ile-Pro-Ile-OH. CAS No. 90614-48-5. Pack Sizes: 500 mg. Product ID: BAT-010802. Molecular formula: C17H31N3O4. Mole weight: 341.45. Custom synthesis is available. Send your inquiries for more information. | London |
| Diprotin A TFA | Diprotin A TFA is a dipeptidyl peptidase IV (DPP-IV) inhibitor. Group: Pharmaceutical. Alternative Names: L-isoleucyl-L-prolyl-L-isoleucine trifluoroacetic acid. CAS No. 209248-71-5. Pack Sizes: 1 g. Product ID: B1370-099112. Molecular formula: C19H32F3N3O6. Mole weight: 455.47. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-Dha-OH | Fmoc-Dha-OH, a pivotal intermediate, is used for synthesizing a plethora of biologically active compounds encompassing antimicrobial peptides, dipeptidyl peptidase IV inhibitors, and enzyme inhibitors. Researchers have employed it to fabricate Fmoc-Dha-OH-derived peptidomimetics manifested by the impeding activity against a myriad of cancer cell lines. The said compound holds sheer potential for the design and development of novel pharmaceutical agents targeting numerous diseases. Group: Pharmaceutical. Alternative Names: Fmoc-dehydro-Ala-OH; N-(9H-Fluorene-9-ylmethoxycarbonyl)-2,3-didehydro-L-alanine; 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)acrylic acid. CAS No. 261522-33-2. Pack Sizes: 500 mg. Product ID: BAT-008269. Molecular formula: C18H15NO4. Mole weight: 309.3. Custom synthesis is available. Send your inquiries for more information. | London |
| Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid | Fmoc-(R)-3-amino-4-(2,4,5-trifluorophenyl)butyric Acid is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: N-β-(9-Fluorenylmethoxycarbonyl)-2,4,5-trifluoro-D-β-homophenylalanine; (R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid. CAS No. 1217818-53-5. Pack Sizes: 1mg;1g;10g. Product ID: BAT-005531. Molecular formula: C25H20F3NO4. Mole weight: 455.43. Custom synthesis is available. Send your inquiries for more information. | London |
| H-Gly-Pro-Hyp-OH | A peptide inhibitor of dipeptidylpeptidase-IV (DPP-IV). Group: Pharmaceutical. Alternative Names: glycyl-prolyl-hydroxyproline; Gly-L-Pro-L-t4Hyp-OH; L-Proline, glycyl-L-prolyl-4-hydroxy-, (4R)-. CAS No. 2239-67-0. Pack Sizes: 500 mg. Product ID: BAT-015714. Molecular formula: C12H19N3O5. Mole weight: 285.3. Custom synthesis is available. Send your inquiries for more information. | London |
| H-Pro-NH2 | An impurity of Vildagliptin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. Alternative Names: L-Prolinamide; (2S)-2-Pyrrolidinecarboxamide; (-)-Prolinamide; (2S)-2-Carbamoylpyrrolidine; (2S)-Pyrrolidine-2-carboxylic acid amide; (S)-2-(Aminocarbonyl)pyrrolidine; (S)-Prolinamide; (S)-Proline Amide; 2-Pyrrolidinecarboxamide, (2S)-; 2-Pyrrolidinecarboxamide, (S)-; Prolinamide, L-; (S)-Pyrrolidine-2-carboxamide; (S)-Pyrrolidine-2-carboxylic acid amide; L-Proline amide. CAS No. 7531-52-4. Pack Sizes: 1mg;1g;10g. Product ID: BAT-003438. Molecular formula: C5H10N2O. Mole weight: 114.1. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Uses: The treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta. CAS No. 668270-12-0. Pack Sizes: 2.5 g. Product ID: NP2669. Molecular formula: C25H28N8O2. Mole weight: 472.553. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 10 (S-Isomer) | a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: (S)-Linagliptin; 8-[(3S)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 668270-11-9. Pack Sizes: 50 mg. Product ID: B0012-473823. Molecular formula: C25H28N8O2. Mole weight: 472.55. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity 7 Hydrochloride | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: (R)-N-(2-Acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide hydrochloride. Pack Sizes: 50 mg. Product ID: B1370-449757. Molecular formula: C25H30ClN7O4. Mole weight: 528. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity B | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-Bromo-3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; 1H-Purine-2,6-dione, 8-bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-; 8-Bromo-3,7-dihydro-3-methyl-1,7-bis[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione. CAS No. 2138392-83-1. Pack Sizes: 10 mg. Product ID: B2694-473825. Molecular formula: C26H21BrN8O2. Mole weight: 557.41. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Impurity E | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: Des-(R)-piperidin-3-amine 8-(R)-(Piperidin-3-ylamino) Linagliptin; (R)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione. CAS No. 1446263-38-2. Pack Sizes: 10 mg. Product ID: B2694-242668. Molecular formula: C25H28N8O2. Mole weight: 472.5. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Methyldimer | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; 8-((R)-3-Aminopiperidin-1-yl)-1-((4-((2-((8-((R)-3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)methyl)-4-methyl-1,4-dihydroquinazolin-4-yl)methyl)quinazolin-2-yl)methyl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; Linagliptin Dimer Impurity. CAS No. 1418133-47-7. Pack Sizes: 10 mg. Product ID: B2694-473827. Molecular formula: C50H56N16O4. Mole weight: 945.08. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Acetyl Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: (R)-N-(1-(7-(But-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)acetamide. CAS No. 1803079-49-3. Pack Sizes: 50 mg. Product ID: B0012-007233. Molecular formula: C27H30N8O3. Mole weight: 514.58. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin N-Boc Impurity | An impurity of Linagliptin. Linagliptin is a dipeptidyl peptidase-4 inhibitor with a hpyerglycemic activity. It was approved for the treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: Linagliptin Related Compound B, N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester. CAS No. 668273-75-4. Pack Sizes: 50 mg. Product ID: B0012-007234. Molecular formula: C30H36N8O4. Mole weight: 572.67. Custom synthesis is available. Send your inquiries for more information. | London |
| Linagliptin Related Compound A | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione; 8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine. CAS No. 666816-98-4. Pack Sizes: 1mg;1g;10g. Product ID: NP2672. Molecular formula: C10H9BrN4O2. Mole weight: 297.11. Custom synthesis is available. Send your inquiries for more information. | London |
| N-acetic acid-1-amino-3-adamantanol | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. Alternative Names: Vildagliptin Impurity 4; (3-hydroxyadamantan-1-ylamino)acetic acid; 2-((3-Hydroxyadamantan-1-yl)amino)acetic acid. CAS No. 1032564-18-3. Pack Sizes: 500 mg. Product ID: B2694-485169. Molecular formula: C12H19NO3. Mole weight: 225.29. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Acetyl Sitagliptin | N-Acetyl Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: 7-[(3R)-3-[(N-Acetyl)Amino]-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine; N-[(2R)-4-Oxo-4-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]acetamide. CAS No. 1379666-94-0. Pack Sizes: 50 mg. Product ID: B2694-479646. Molecular formula: C18H17F6N5O2. Mole weight: 449.35. Custom synthesis is available. Send your inquiries for more information. | London |
| N-Cyano-N'-methyl-ethanimidamide | N-Cyano-N'-methyl-ethanimidamide has exhibited significant inhibitory activity against the dipeptidyl peptidase IV (DPP-4), which represents a pharmacological target for mitigating type 2 diabetes. In addition to this, the product has demonstrated antiviral potential against a diverse range of viral strains, among which the human immunodeficiency virus (HIV) is notable. The product's diverse clinical applications thus mandate in-depth investigation and analysis. Group: Pharmaceutical. Alternative Names: 1-Cyanoimino-N-methylethanamine. CAS No. 56563-12-3. Pack Sizes: 5 g. Product ID: B1370-015289. Molecular formula: C4H7N3. Mole weight: 97.12. Custom synthesis is available. Send your inquiries for more information. | London |
| Omarigliptin | Omarigliptin is a potent and selective dipeptidyl peptidase 4 (DPP-4) inhibitor to be used as the treatment for type 2 diabetes. Group: Pharmaceutical. Alternative Names: MK-3102; MK3102; MK 3102; (2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine. CAS No. 1226781-44-7. Pack Sizes: 25 mg. Product ID: B0084-462292. Molecular formula: C17H20F2N4O3S. Mole weight: 398.429. Custom synthesis is available. Send your inquiries for more information. | London |
| PMPA sodium salt | PMPA is an inhibitor of glutamate carboxypeptidase 2 (GCP II/N-acetylated a-linked dipeptidase/NAALADase). Group: Pharmaceutical. Alternative Names: PMPA tetrasodium. CAS No. 373645-42-2. Pack Sizes: 50 mg. Product ID: B2693-342069. Molecular formula: C6H7Na4O7P. Mole weight: 314.05. Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide | (R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzamide is an impurity of alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. Alternative Names: Alogliptin Impurity 14; Alogliptin Carbamoyl Impurity. CAS No. 1820685-30-0. Pack Sizes: 100 mg. Product ID: B1370-377540. Molecular formula: C18H23N5O3. Mole weight: 357.41. Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-3-(Boc-amino)piperidine | (R)-3-(Boc-amino)piperidine is an impurity of Alogliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor in the class of oral antidiabetic drugs. Group: Pharmaceutical. Alternative Names: Carbamic acid, N-(3R)-3-piperidinyl-, 1,1-dimethylethyl ester; 1,1-Dimethylethyl N-(3R)-3-piperidinylcarbamate; Carbamic acid, (3R)-3-piperidinyl-, 1,1-dimethylethyl ester; (3R)-3-[((tert-Butyloxycarbonyl)amino)]piperidine; (R)-3-(N-Boc-amino) piperidine; (R)-3-(tert-Butoxycarbonylamino)piperidine; (R)-3-[(tert-Butoxycarbonyl)amino]piperidine; (R)-3-[(tert-Butyloxycarbonyl)amino]piperidine; (R)-3-[N-(tert-Butoxycarbonyl)amino]piperidine; (R)-3-tert-Butoxycarbonylaminopiperidine; (R)-Piperidin-3-ylcarbamic acid tert-butyl ester; (R)-tert-Butyl (piperidin-3-yl)carbamate; tert-Butyl (R)-N-(3-piperidyl)carbamate; tert-Butyl (R)-N-(piperidin-3-yl)carbamate; tert-Butyl (R)-piperidin-3-ylcarbamate; tert-Butyl N-((3R)-3-piperidyl)carbamate. CAS No. 309956-78-3. Pack Sizes: 1mg;1g;10g. Product ID: NP2670. Molecular formula: C10H20N2O2. Mole weight: 200.28. Custom synthesis is available. Send your inquiries for more information. | London |
| (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione | An impurity of Linagliptin, a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. Group: Pharmaceutical. Alternative Names: 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione; Linagliptin Impurity C. CAS No. 1791405-13-4. Pack Sizes: 100 mg. Product ID: B1370-377743. Molecular formula: C15H20N6O2. Mole weight: 316.36. Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Sitagliptin | Rac-Sitagliptin is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Uses: Dipeptidyl-peptidase iv inhibitors. Group: Pharmaceutical. Alternative Names: Sitagliptin Raccemate; Sitagliptin impurity E; 7-[3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine; 4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine. CAS No. 823817-56-7. Pack Sizes: 50 mg. Product ID: B2693-211737. Molecular formula: C16H15F6N5O. Mole weight: 407.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Rac-Vildagliptin Impurity F | An impurity of Vildagliptin. Vildagliptin is a new dipeptidyl peptidase-4 (DPP-4) inhibitor that is used as an anti-hyperglycemic agent. Vildagliptin could reduce hyperglycemia in type 2 diabetes mellitus via the suppressive effect of inactivation of GLP-1 and GIP by DPP-4. Group: Pharmaceutical. Alternative Names: Vildagliptin Impurity C (IP); Vildagliptin Related Compound 3; Vildagliptin Lactam; 2-(3-Hydroxy-adamant-1-yl)-hexahydro-pyrrolo[1,2-a]pyrazine-1,4-dione; Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-; Hexahydro-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)pyrrolo[1,2-a]pyrazine-1,4-dione; 2-(3-Hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione. CAS No. 1789703-36-1. Pack Sizes: 10 mg. Product ID: B2694-485167. Molecular formula: C17H24N2O3. Mole weight: 304.39. Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Cyclic Amide | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. Alternative Names: Saxagliptin EP Impurity C. CAS No. 1350800-77-9. Pack Sizes: 2.5 mg. Product ID: B0016-479457. Molecular formula: C18H24N2O3. Mole weight: 316.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Cyclic Amidine Impurity | An impurity of saxagliptin. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for the treatment of type II diabetes. Group: Pharmaceutical. Alternative Names: Saxagliptin EP Impurity A; (1aS,4S,6aR,7aS)-6-Amino-1,1a,4,6a,7,7a-hexahydro-4-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-3H-Cyclopropa[4,5]pyrrolo[1,2-a]pyrazin-3-one. CAS No. 1350800-76-8. Pack Sizes: 5 mg. Product ID: B0016-479455. Molecular formula: C18H25N3O2. Mole weight: 315.42. Custom synthesis is available. Send your inquiries for more information. | London |
| Saxagliptin Keto Impurity | An impurity of Saxagliptin. Saxagliptin is an inhibitor of dipeptidyl peptidase-4 (DPP-4) used as a hypoglycemic drug. It was approved to treat type 2 diabetes. Group: Pharmaceutical. Alternative Names: (1S,3S,5S)-2-((R)-2-amino-2-((1s,3R,5S,7S)-4-oxoadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile. Pack Sizes: 2.5 mg. Product ID: B0016-007239. Molecular formula: C18H23N3O2. Mole weight: 313.4. Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity A Phosphate | Sitagliptin EP Impurity A Phosphate is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: Sitagliptin S-Isomer Phosphate; ent-Sitagliptin Phosphate; (S)-Sitagliptin Phosphate; 7-[(3S)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine Phosphate. CAS No. 823817-58-9. Pack Sizes: 100 mg. Product ID: B0017-479659. Molecular formula: C16H15F6N5O.H3PO4. Mole weight: 505.31. Custom synthesis is available. Send your inquiries for more information. | London |
| Sitagliptin EP Impurity B | Sitagliptin EP Impurity B is an impurity of Sitagliptin. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Group: Pharmaceutical. Alternative Names: Sitagliptin Analog 13; 4-Desfluoro Sitagliptin; (R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,5-difluorophenyl)butan-2-amine. CAS No. 486460-31-5. Pack Sizes: 25 mg. Product ID: B2694-479656. Molecular formula: C16H16F5N5O. Mole weight: 389.32. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
